A Review of Classification of Emerging Excipients in Parenteral Medications

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-03-02-2003, Volume 27, Issue 3

As parenteral drug delivery becomes more complex and sophisticated, excipients that can facilitate drug (or gene) delivery to specific therapeutic targets will be required. An overwhelming majority of these excipients are derived from natural sources.

Related Content:

ManufacturingExcipientsDevelopmentParenteralsDosage FormsManufacturing, Parenterals and InjectablesManufacturing, Drug ProductsPharmaceutical Technology-03-02-2003
Alentis Therapeutics to Advance Anti-Claudin-1 ADCs to Treat Solid Tumors on $181.4 Million Financing
Frontier Scientific Solutions Plans a Global Free Trade Zone Gateway to Supply Life Sciences Industry on Back of $1.5 Billion Investment
EMA’s CHMP Gives Positive Opinion for Use of Lecanemab in Early Alzheimer’s Disease